The influence of pretransplant interferon-α therapy on survival after allogenous BMT in patients with CML.

被引：0
|
作者：
Hochhaus, A [1 ]
Kolb, HJ [1 ]
Hasford, J [1 ]
Berger, U [1 ]
Muth, A [1 ]
Pfirrmann, M [1 ]
Hehlmann, R [1 ]
机构：
[1] Univ Heidelberg, Klinikum Mannheim, Med Klin, Mannheim, Germany
来源：
BONE MARROW TRANSPLANTATION | 1999年 / 23卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
191
引用
收藏
页码：S59 / S59
页数：1
相关论文
共 50 条
  • [31] PEG-interferon α-2A (Pegasys™) with or without cytarabine in patients with relapsed or refractory chronic phase CML.
    Talpaz, M
    Cortes, J
    O'Brien, S
    Wenske, C
    Rittweger, K
    Rakhit, A
    Hooftman, L
    Kantarjian, H
    BLOOD, 2000, 96 (11) : 736A - 737A
  • [32] Pericarditis after therapy with interferon-α for chronic hepatitis C
    Boonen, A
    Stockbrügger, RW
    van der Linden, S
    CLINICAL RHEUMATOLOGY, 1999, 18 (02) : 177 - 179
  • [33] Acute respiratory failure after interferon-γ therapy in IPF
    Crestani, B
    Valeyre, D
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 169 (04) : 544 - 544
  • [34] Interferon-α and interferon-γ in advanced renal cell carcinoma:: Treatment results, survival, and prognostic factors in 81 patients
    Lümmen, G
    Sperling, H
    Luboldt, H
    Otto, T
    Rübben, H
    ONKOLOGIE, 1997, 20 (06): : 466 - 471
  • [35] Absence of influence of prior interferon alfa (IFN alpha) therapy on the outcome of allogeneic bone marrow transplantation (BMT) for chronic myelogenous leukemia (CML).
    Tomas, IF
    Steegman, IL
    Requena, MI
    Soria, VGG
    FernandezRanada, IM
    BLOOD, 1995, 86 (10) : 3859 - 3859
  • [36] The influence of interferon-α and combination interferon-α and lamivudine therapy on height and weight in children with chronic hepatitis B infection
    Kuloglu, Zarife
    Kansu, Aydan
    Demirceken, Fulya
    Arici, Z. Serap
    Berberoglu, Merih
    Ocal, Gonul
    Girgin, Nurten
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2007, 20 (05): : 615 - 620
  • [37] A combined therapeutic strategy of T-cell depletion of BMT and incremental doses of donor lymphocyte infusion (DLI) for relapsing patients with CML.
    Novitzky, N
    Rubinstein, R
    Hallett, J
    du Toit, C
    Thomas, V
    Abrahams, L
    BLOOD, 1998, 92 (10) : 353B - 353B
  • [38] Interferon-α therapy for patients with molecular relapse in leukemia after allogeneic stem cell transplantation
    Murai, K
    Sugawara, T
    Oyake, T
    Kowata, S
    Numaoka, H
    Suzuki, K
    Ishida, Y
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (02) : 61 - 61
  • [39] Adjuvant Treatment with Alpha Interferon (IFN) for Patients at High Risk for Relapse after Allogeneic Transplantation (BMT) for Chronic Myelogenous Leukemia (CML)
    Bezerra, Evandro Dantas
    Radich, Jerald
    Flowers, Mary E.
    Chielins, Debbie
    Higano, Celestia
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S238 - S238
  • [40] Collection of Ph-negative progenitor cells from Ph+ CML patients in complete cytogenetic remission after long-term interferon-α therapy
    Russo, D
    Martinelli, G
    Montefusco, V
    Amabile, M
    Rosti, G
    Marin, L
    HAEMATOLOGICA, 1999, 84 (10) : 953 - 955
12345